# Contract documentation proposal

**Initiative:** Contract documentation  
**Proposal status:** Draft  
**Revision:** 0.1  
**Last updated:** 2026-11-11  
**Owner:** User  
**Initiative type:** `implementation`  
**Work version:** `v1.0`  
**Realization suite:** [`RZN-001-P1-DOCS-SUITE`](../../../../../evidence/non-authoritative/realizations/v1.0/00-RZN-001-P1-DOCS-suite-index.md)
**Type requirements:** See [the initiative template](../README.md#initiative-type-and-output-boundary).

## Executive proposal

Propose one documentation-only implementation initiative that creates a
versioned derivative guide to the accepted example-record architecture and
security policies. The guide would make the D1 contracts navigable for later
implementers and users while exact authoritative records retain all normative
meaning and while no D2–D6 product or conformance result is claimed.

## Initiative type and permitted output

This is an `implementation` initiative. Its permitted output is derivative
product documentation and its product-facing navigation material. It may not
change an authoritative architecture or security record, another initiative
specification, a reusable template, or an executable product.

## Problem and evidence

Architecture `ARC-SUITE-001@2.0.1` and the NIST and HIPAA security suites are
complete, precise, and binding, but they are organized as authority records
rather than one audience-oriented product. The non-authoritative
`RZN-001-P1-DOCS-N01` note identifies a coherent D1 opportunity and preserves
six publication decisions that have not been made. `ARC-CTR-009` defines a D1
structural gate but explicitly supplies no implementation or completion
evidence.

## Intended outcomes

1. Readers can locate the exact authoritative owner of each documented domain,
   API, search, persistence, SDK, CLI, web, platform, security, and evidence
   claim.
2. Every entry point states the local, single-user, Compose-only,
   non-production, synthetic/documented-de-identified boundary and the
   prohibited claims.
3. A documentation-only review can verify coverage, links, terminology,
   examples, revision identity, and claim discipline without implying that any
   executable product exists.

## Scope

### Included

- A versioned derivative documentation set, source map, glossary, examples,
  audience navigation, and compatibility/evidence guidance.
- Documentation verification for source identity, coverage, internal links,
  terminology, safe synthetic examples, accessibility/usability, and truthful
  claims.

### Excluded

- Any Docker, API, SQLite, SDK, CLI, browser, test, deployment, or release
  artifact owned by D2–D6.
- Any revision of authoritative evidence, acceptance of an open publication
  choice, or assertion of implementation, conformance, NIST certification,
  HIPAA compliance, or ePHI suitability.

## Users and stakeholders

| Stakeholder or affected party | Need or responsibility | Expected change |
|---|---|---|
| Future D2–D6 implementers | Find exact contracts and limits | Use one derivative entry point linked to binding sources |
| Local operators and product users | Understand supported use and safe lifecycle | Receive consistent limitation and source guidance |
| Architecture and security reviewers | Detect drift and overclaim | Review explicit source and claim mappings |
| User, as Sole Project Owner | Decide publication choices and later acceptance | Review the six unresolved decisions and evidence |

## Terms

| Term | Meaning in this proposal |
|---|---|
| Derivative documentation | Explanatory product content whose meaning remains owned by cited authoritative evidence |
| D1 | The independent architecture and contract documentation delivery unit in `ADR-007` |
| Normative source | A precise record under `evidence/authoritative` that governs a documented claim |
| Observed result | Exact-artifact verification evidence, which does not yet exist for D2–D6 |

## Proposed direction

### Product behavior or placement

Create one coherent documentation product, with its exact repository or
publishing destination left open for `DOC-01`. The product should favor direct
links and compact derivative explanations, label examples as non-normative,
and keep generated material subordinate to accepted Markdown contracts.

### Domain and authority model

The authoritative architecture owns technical meaning; the NIST and HIPAA
suites independently own security, use, safeguard, and evidence requirements.
The derivative product owns only presentation, navigation, examples, and
source traceability. A conflict blocks publication and routes through
`ADR-006`; documentation never edits authority to match an implementation.

### System boundaries

The initiative changes documentation only. It may describe all D1–D6
interfaces but must not create, configure, exercise, or claim their products.
Realization evidence is proposal input and never overrides authority.

### Primary workflows

1. Inventory exact source revisions and map each derivative claim to its owner.
2. Author the approved audience structure and safe examples at the destination
   selected by human decision.
3. Run structural, semantic, accessibility/usability, and claim-language review
   and preserve limitations with the exact documentation revision.

### Data and lifecycle

Only purpose-created synthetic examples or externally documented de-identified
examples that also satisfy the NIST restrictions may be used. Documentation
versions identify the architecture and security revisions consumed. A semantic
source change requires compatibility review and a traceable successor; a
passing document check never becomes product runtime evidence.

## Operational behavior

### Failure and recovery

Broken sources, contradictory wording, unsafe examples, generated drift, or an
overbroad claim block the affected publication. Recovery restores the last
reviewed derivative or corrects it against the unchanged authoritative source;
no automatic regeneration may silently redefine meaning.

### Security and authorization

The product carries the exact local/non-production limitation, uses safe
examples, stores no credentials or real-person data, and links all successor
triggers. Human publication choices and acceptance remain with the User under
the project ownership convention.

### Observability

Review output records source revision, document revision, link/structure
results, coverage, example checks, accessibility/usability method, limitations,
and reviewer. It records no runtime health or conformance claim.

## Compatibility and transition

The first derivative release must name `ARC-SUITE-001@2.0.1`,
`SEC-NIST-SUITE-001@1.0.1`, and `SEC-HIPAA-SUITE-001@1.0.1`. Later source
changes follow `ADR-006`; the prior documentation remains identifiable. D2–D6
artifacts consume an exact documentation/source revision only through their
own separately evidenced initiatives.

## Alternatives considered

| Alternative | Benefit | Cost or reason not selected |
|---|---|---|
| Use the authoritative suites directly | No derivative drift | Does not supply the requested audience navigation and examples |
| Generate all documentation from future products | Easy synchronization with code | Products do not yet exist and generated behavior cannot own accepted meaning |
| Combine D1 with executable delivery | One apparent release | Violates `ADR-007` and obscures independent acceptance claims |

## Risks and tradeoffs

| Risk or tradeoff | Impact | Mitigation or evidence needed |
|---|---|---|
| Copied normative text drifts | Readers follow stale meaning | Prefer exact links and run revision/semantic review |
| Audience groups become separate products | One initiative becomes an umbrella | Resolve `DOC-02` and re-run split triggers |
| Generated output becomes de facto authority | Implementation defects replace contracts | Label and drift-check every generated derivative |
| Examples leak or imply unsafe use | Evidence leaves the permitted profile | Synthetic provenance and claim/data review |

## Assumptions requiring assumption

- One derivative D1 set can remain a single independently reviewable
  documentation outcome while serving several audiences.
- Exact authoritative sources remain the sole owners of normative meaning and
  will be linked rather than silently copied.
- Documentation can be delivered and reviewed without waiting for D2–D6
  implementation evidence, provided every runtime claim remains prospective.

## Questions requiring decisions

- Which repository paths or publishing destination own the derivative set?
- Which audience-specific documents remain one acceptance claim, and which
  would require separate narrow work?
- What portion is authored versus generated, and what drift check protects it?
- What version identity and cadence tie the set to source and product versions?
- What review verifies documentation accessibility and usability without
  confusing that result with D6 accessibility?
- Who owns security-source currency, legal disclaimers, and product review?

## Acceptance outcomes

- The selected documentation product is complete for its accepted D1 scope,
  source-accurate, internally coherent, navigable, accessible under the chosen
  review, and free of unresolved blocking publication decisions.
- Every normative statement, example, limitation, and claimed result traces to
  exact authority or evidence, and the product makes no D2–D6, certification,
  compliance, release, or regulated-use claim.

## References

- [`RZN-001-P1-DOCS-N01`](../../../../../evidence/non-authoritative/realizations/v1.0/01-RZN-001-P1-DOCS-contract-documentation.md) — primary non-authoritative realization input.
- [`ARC-SUITE-001@2.0.1`](../../../../../evidence/authoritative/architecture/00-architecture-suite-index.md) and [`ARC-CTR-009`](../../../../../evidence/authoritative/architecture/24-conformance-contract.md) — binding D1 contracts and gate.
- [`SEC-NIST-SUITE-001@1.0.1`](../../../../../evidence/authoritative/security/NIST/00-nist-security-policy-suite-index.md) and [`SEC-HIPAA-SUITE-001@1.0.1`](../../../../../evidence/authoritative/security/HIPPA/00-hipaa-security-policy-suite-index.md) — binding security and use limits.

## Revision history

| Revision | Date | Owner | Change |
|---|---|---|---|
| 0.1 | 2026-11-11 | User | Initial proposal; all publication choices remain open |
